| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Regeneron Pharmaceuticals, Inc. (REGN) has 19 insiders with recent SEC Form 4 filings, including 0 buys and 47 sells. REGN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Pres | 310.5K | $189.36M | - | |
| CEO | 214.5K | $130.85M | - | |
| VP | 47.8K | $29.18M | - | |
| VP | 29.5K | $18.00M | - | |
| VP | 21.7K | $13.22M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 7, 2022 | Van Plew Daniel P | EVP &General Mgr, Industrial | Sale+OE | 7,886 | $745.40 | $5,878,262.92 | -3.7% | +4.0% | +10.6% | |
| Nov 4, 2022 | McCourt Marion55 | EVP Commercial | Sale+OE | 1,000 | $727.82 | $727,820.00 | -4.8% | +1.5% | +10.4% | |
| Nov 1, 2022 | Ryan Arthur F54 | Director | Sell | 100 | $755.89 | $75,588.55 | - | -3.1% | +4.1% | |
| Nov 1, 2022 | McCourt Marion55 | EVP Commercial | Sale+OE | 1,100 | $750.00 | $825,000.00 | -5.3% | -3.1% | +4.1% | |
| Nov 1, 2022 | Landry Robert E52 | EVP Finance CFO | Sale+OE | 482 | $758.06 | $365,386.44 | -0.2% | -3.1% | +4.1% | |
| Oct 17, 2022 | Landry Robert E52 | EVP Finance CFO | Sale+OE | 358 | $739.50 | $264,741.00 | -1.2% | -1.1% | +13.7% | |
| Oct 5, 2022 | Fenimore Christopher R.66 | SVP Controller | Sell | 1,844 | $749.00 | $1,381,156.00 | -10.1% | -3.4% | +11.5% | |
| Oct 3, 2022 | Ryan Arthur F54 | Director | Sell | 100 | $726.54 | $72,654.30 | - | -2.0% | +10.0% | |
| Oct 3, 2022 | McCourt Marion55 | EVP Commercial | Sale+OE | 1,100 | $705.39 | $775,929.00 | -2.7% | -2.0% | +10.0% | |
| Oct 3, 2022 | Fenimore Christopher R.66 | SVP Controller | Sell | 3,346 | $724.00 | $2,422,504.00 | -15.5% | -2.0% | +10.0% |